Search Site close Close
News

Clinical Study Seeks Participants with Lung Disease

Published Date:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes harder to take deep breaths. The lungs become unable to take in enough oxygen.

Dr. Rajagopal Sreedhar is recruiting participants for a clinical trial to see if pulmonary rehabilitation treatments improve the quality of life for patients with IPF. The study will compare standard of care treatment to exercise and education. The goal is test how well the combination of exercise and medication benefits the patient. All study-related visits and tests will be provided at no cost to the participant. Participants may also receive a stipend to cover travel and other related expenses.

To qualify, participants must:

  • Be 40 years of age or older
  • Have been diagnosed with IPF
  • Be currently taking the medication Ofev® (150 mg twice a day) and have taken it at a stable dose for up to 30 months

To learn more about this study, contact Abigail House, RN, at 217-545-7526.

More from SIU News

Dr. Judy Davie in her lab in Carbondale

From lab to lecture hall, Dr. Judy Davie champions future scientists

Dr. Judy Davie has built a career grounded in discovery, collaboration and mentorship, studying how genes guide muscle development and how cancers disrupt those processes.
Roland and Linda Folse

Generosity as an art form

SIU School of Medicine’s 2025 Distinguished Donors of the Year are a remarkable couple whose unwavering generosity and passion have left a lasting imprint on the school and the region.
Phil Jensik's lab in Carbondale

Major grant boosts SIU’s genetic therapy research

In a laboratory at SIU School of Medicine in Carbondale, scientists are working quietly toward a future that could change the outlook for families affected by rare neurodevelopmental disorders.